The environment of the pharmaceutical industry changed in the second half of the 1970s as laws prohibiting drug substitution were repealed. We studied the adaptation of marketing by pharmaceutical firms to the new environment. Evidence presented shows that pharmaceutical firms increased their marketing efforts directed at pharmacists but did not change the content of their advertising. Few attempts have been made to advertise directly to consumers.
Get full access to this article
View all access options for this article.
References
1.
DeliboriDana (1981), “Some Manufacturers Weigh Promoting Rx Brand Names to Patients,”American Druggist (April), p. 97.
2.
Federal Trade Commission (1979), Drug Product Selection.Washington, D.C.: U.S. Government Printing Office.
3.
GoldbergTheodore, DeVitoCarolee A., SmithDavid, DicksonW. Michael, MooreWillis E., and VidisJerry (1978), “Product Choices of Pharmacists When Filling Generically Written Prescriptions,” presented to the 125th Annual Meeting of the American Pharmaceutical Association, Montreal, May 17.
4.
IMS International Ltd., National Journal Audit.Ambler, PA.
5.
JohnsonRobert (1982), “Sparks Fly Over Substitution,”Drug Topics (June 7), p. 36.
6.
New Drug Analysis (1976). New York: Paul deHaen, Inc.
7.
Newsweek (1982), “Ads Over the Doctor's Head,” (March 15), p. 69.
8.
Pharmacy Times (1981), “Generic Rxs Rise by 5.9% as Branded Rxs Increase by Only 1.6%,” (April), pp. 17–25.
